Nutritional supplementation in children with severe pneumonia in Uganda and Kenya (COAST-Nutrition): a phase 2 randomised controlled trial.

Autor:	Kiguli S; Department of Paediatrics, School of Medicine, Makerere University and Mulago Hospital Kampala, Uganda., Olupot-Olupot P; Busitema University Faculty of Health Sciences, Mbale Campus, Uganda.; Mbale Regional Referral Hospital Mbale, Uganda., Hamaluba M; Kilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya., Giallongo E; Clinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), London, UK., Thomas K; Clinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), London, UK., Alaroker F; Soroti Regional Referral Hospital, Soroti, Uganda., Opoka RO; Department of Paediatrics, School of Medicine, Makerere University and Mulago Hospital Kampala, Uganda.; Jinja Regional Referral Hospital Jinja, Uganda., Tagoola A; Jinja Regional Referral Hospital Jinja, Uganda., Oyella S; Masaka Regional Referral Hospital Masaka, Uganda., Nalwanga D; Department of Paediatrics, School of Medicine, Makerere University and Mulago Hospital Kampala, Uganda., Nabawanuka E; Department of Paediatrics, School of Medicine, Makerere University and Mulago Hospital Kampala, Uganda.; Department of Radiology, School of Medicine, Makerere University, P.O Box 7072, Kampala, Uganda., Okiror W; Busitema University Faculty of Health Sciences, Mbale Campus, Uganda.; Mbale Regional Referral Hospital Mbale, Uganda., Nakuya M; Soroti Regional Referral Hospital, Soroti, Uganda., Amorut D; Soroti Regional Referral Hospital, Soroti, Uganda., Muhindo R; Mbale Regional Referral Hospital Mbale, Uganda., Ayub Mpoya; Kilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya., Mnjalla H; Kilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya., Oguda E; Kilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya., Williams TN; Kilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya.; Department of Infectious Disease and Institute of Global Health and Innovation, Imperial College London, London, UK., Harrison DA; Clinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), London, UK., Rowan K; Clinical Trials Unit, Intensive Care National Audit & Research Centre (ICNARC), London, UK., Briend A; Tampere Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.; Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Frederiksberg, Denmark., Maitland K; Kilifi County Hospital and Kenya Medical Research Institute (KEMRI) Wellcome Trust Research Programme, Kilifi, Kenya.; Department of Infectious Disease and Institute of Global Health and Innovation, Imperial College London, London, UK.
Jazyk:	angličtina
Zdroj:	EClinicalMedicine [EClinicalMedicine] 2024 May 14; Vol. 72, pp. 102640. Date of Electronic Publication: 2024 May 14 (Print Publication: 2024).
DOI:	10.1016/j.eclinm.2024.102640
Abstrakt:	Background: Severe pneumonia in African children results in poor long-term outcomes (deaths/readmissions) with undernutrition as a key risk factor. We hypothesised additional energy/protein-rich Ready-to-Use Therapeutic Foods (RUTF) would meet additional nutritional requirements and improve outcomes. Methods: COAST-Nutrition was an open-label Phase 2 randomised controlled trial in children (aged 6 months-12 years) hospitalised with severe pneumonia (and hypoxaemia, SpO 2 <92%) in Mbale, Soroti, Jinja, Masaka Regional Referral Hospitals, Uganda and Kilifi County Hospital, Kenya (ISRCTN10829073 (registered 6th June 2018) PACTR202106635355751 (registered 2nd June 2021)). Children were randomised (ratio 1:1) to enhanced nutritional supplementation with RUTF (plus usual diet) for 56 days vs usual diet (control). The primary outcome was change in mid-upper arm circumference (MUAC) at 90 days as a composite with mortality. Secondary outcomes include anthropometric status, mortality, and readmissions at Days 28, 90 and 180. Findings: Between 12 August 2018 and 22 April 2022, 846 eligible children were randomised, 424 to RUTF and 422 to usual diet, and followed for 180-days [12 (1%) lost-to-follow-up]. RUTF supplement was initiated in 417/419 (>99%). By Day 90, there was no significant difference in the composite endpoint (probabilistic index 0.49, 95% CI 0.45-0.53, p = 0.74). Respective 90-day mortality (13/420 3.1% vs 14/421 3.3%) and MUAC increment (0.54 (SD 0.85) vs 0.55 (SD 0.81)) were similar between arms. There was no difference in any anthropometric secondary endpoints to Day 28, 90 or 180 except skinfold thickness at Day 28 and Day 90 was greater in the RUTF arm. Serious adverse events were higher in the RUTF arm (n = 164 vs 108), mainly due to hospital readmission for acute illness (54/387 (14%) vs 37/375 (10%). Interpretation: Our study suggested that nutritional supplementation with RUTF did not improve outcomes to 180 days in children with severe pneumonia. Funding: This trial is part of the EDCTP2 programme (grant number RIA-2016S-1636-COAST-Nutrition) supported by the European Union, and UK Joint Global Health Trials scheme: Medical Research Council, Department for International Development, Wellcome Trust (grant number MR/L004364/1, UK). Competing Interests: The authors declare that they have no competing interests. (© 2024 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu